Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer. - Zhang M; Niu L; Lyu H; Liu Z; Zeng H; Lu Z; Chen X; Qiao J; Yuan P; Zhao S; Sun H; Wang J; et al. (Chinese medical journal, 2026)